{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:27:01Z","timestamp":1791415621858,"version":"4.3.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2005,5,22]],"date-time":"2005-05-22T00:00:00Z","timestamp":1116720000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1038\/nm1255","type":"journal-article","created":{"date-parts":[[2005,5,22]],"date-time":"2005-05-22T13:15:49Z","timestamp":1116767749000},"page":"774-779","source":"Crossref","is-referenced-by-count":313,"title":["Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors"],"prefix":"10.1038","volume":"11","author":[{"given":"Aymen I","family":"Idris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"van 't Hof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain R","family":"Greig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A","family":"Ridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth A","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart H","family":"Ralston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,5,22]]},"reference":[{"key":"BFnm1255_CR1","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","volume":"289","author":"SL Teitelbaum","year":"2000","unstructured":"Teitelbaum, S.L. Bone resorption by osteoclasts. Science 289, 1504\u20131508 (2000).","journal-title":"Science"},{"key":"BFnm1255_CR2","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/jemt.10375","volume":"61","author":"MH Helfrich","year":"2003","unstructured":"Helfrich, M.H. Osteoclast diseases. Microsc. Res. Tech. 61, 514\u2013532 (2003).","journal-title":"Microsc. Res. Tech."},{"key":"BFnm1255_CR3","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","volume":"289","author":"GA Rodan","year":"2000","unstructured":"Rodan, G.A. & Martin, T.J. Therapeutic approaches to bone diseases. Science 289, 1508\u20131514 (2000).","journal-title":"Science"},{"key":"BFnm1255_CR4","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","volume":"142","author":"S Khosla","year":"2001","unstructured":"Khosla, S. Minireview: The OPG\/RANKL\/RANK System. Endocrinology 142, 5050\u20135055 (2001).","journal-title":"Endocrinology"},{"key":"BFnm1255_CR5","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1172\/JCI0214588","volume":"109","author":"PA Baldock","year":"2002","unstructured":"Baldock, P.A. et al. Hypothalamic Y2 receptors regulate bone formation. J. Clin. Invest. 109, 915\u2013921 (2002).","journal-title":"J. Clin. Invest."},{"key":"BFnm1255_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S0165-6147(00)01642-4","volume":"22","author":"TM Skerry","year":"2001","unstructured":"Skerry, T.M. & Genever, P.G. Glutamate signalling in non-neuronal tissues. Trends Pharmacol. Sci. 22, 174\u2013181 (2001).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnm1255_CR7","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1210\/en.2004-0205","volume":"145","author":"RJ van't Hof","year":"2004","unstructured":"van't Hof, R.J., Macphee, J., Libouban, H., Helfrich, M.H. & Ralston, S.H. . Regulation of bone mass and bone turnover by neuronal nitric oxide synthase. Endocrinology 145, 5068\u20135074 (2004).","journal-title":"Endocrinology"},{"key":"BFnm1255_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0092-8674(00)81558-5","volume":"100","author":"P Ducy","year":"2000","unstructured":"Ducy, P. et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100, 197\u2013207 (2000).","journal-title":"Cell"},{"key":"BFnm1255_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0092-8674(02)01049-8","volume":"111","author":"S Takeda","year":"2002","unstructured":"Takeda, S. et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 111, 305\u2013317 (2002).","journal-title":"Cell"},{"key":"BFnm1255_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1054\/plef.2001.0341","volume":"66","author":"RG Pertwee","year":"2002","unstructured":"Pertwee, R.G. & Ross, R.A. Cannabinoid receptors and their ligands. Prostaglandins Leukot. Essent. Fatty Acids 66, 101\u2013121 (2002).","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"BFnm1255_CR11","doi-asserted-by":"crossref","unstructured":"Ravinet, T.C. et al. Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284, R345\u2013R353 (2003).","DOI":"10.1152\/ajpregu.00545.2002"},{"key":"BFnm1255_CR12","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/00008877-200312000-00001","volume":"14","author":"LP Shearman","year":"2003","unstructured":"Shearman, L.P. et al. Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice. Behav. Pharmacol. 14, 573\u2013582 (2003).","journal-title":"Behav. Pharmacol."},{"key":"BFnm1255_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0014-2999(03)01343-8","volume":"462","author":"AL Hildebrandt","year":"2003","unstructured":"Hildebrandt, A.L., Kelly-Sullivan, D.M. & Black, S.C. Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet\u2013induced obese mice. Eur. J. Pharmacol. 462, 125\u2013132 (2003).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnm1255_CR14","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","volume":"3","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi, H. et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889\u2013901 (2002).","journal-title":"Dev. Cell"},{"key":"BFnm1255_CR15","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1242\/jcs.00082","volume":"115","author":"JP David","year":"2002","unstructured":"David, J.P., Sabapathy, K., Hoffmann, O., Idarraga, M.H. & Wagner, E.F. JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. J. Cell Sci. 115, 4317\u20134325 (2002).","journal-title":"J. Cell Sci."},{"key":"BFnm1255_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1126\/science.7939685","volume":"266","author":"AE Grigoriadis","year":"1994","unstructured":"Grigoriadis, A.E. et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266, 443\u2013448 (1994).","journal-title":"Science"},{"key":"BFnm1255_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1124\/pr.54.2.161","volume":"54","author":"AC Howlett","year":"2002","unstructured":"Howlett, A.C. et al. International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors. Pharmacol. Rev. 54, 161\u2013202 (2002).","journal-title":"Pharmacol. Rev."},{"key":"BFnm1255_CR18","first-page":"129","volume":"80","author":"N Takahashi","year":"2003","unstructured":"Takahashi, N., Udagawa, N., Tanaka, S. & Suda, T. Generating murine osteoclasts from bone marrow. Methods Mol. Med. 80, 129\u2013144 (2003).","journal-title":"Methods Mol. Med."},{"key":"BFnm1255_CR19","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1359\/jbmr.2000.15.8.1467","volume":"15","author":"FP Coxon","year":"2000","unstructured":"Coxon, F.P. et al. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298. J. Bone Miner. Res. 15, 1467\u20131476 (2000).","journal-title":"J. Bone Miner. Res."},{"key":"BFnm1255_CR20","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1359\/jbmr.2004.19.10.1651","volume":"19","author":"RJ van't Hof","year":"2004","unstructured":"van't Hof, R.J. et al. Identification of biphenylcarboxylic acid derivatives as a novel class of bone resorption inhibitors. J.Bone Miner.Res. 19, 1651\u20131660 (2004).","journal-title":"J.Bone Miner.Res."},{"key":"BFnm1255_CR21","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1124\/mol.53.3.504","volume":"53","author":"AC Howlett","year":"1998","unstructured":"Howlett, A.C., Song, C., Berglund, B.A., Wilken, G.H. & Pigg, J.J. Characterization of CB1 cannabinoid receptors using receptor peptide fragments and site-directed antibodies. Mol. Pharmacol. 53, 504\u2013510 (1998).","journal-title":"Mol. Pharmacol."},{"key":"BFnm1255_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1172\/JCI200316116","volume":"111","author":"ML Casanova","year":"2003","unstructured":"Casanova, M.L. et al. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J. Clin. Invest. 111, 43\u201350 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnm1255_CR23","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1093\/brain\/awg224","volume":"126","author":"G Pryce","year":"2003","unstructured":"Pryce, G. et al. Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain 126, 2191\u20132202 (2003).","journal-title":"Brain"},{"key":"BFnm1255_CR24","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1210\/endo.142.2.7977","volume":"142","author":"KE Armour","year":"2001","unstructured":"Armour, K.E. et al. Defective bone formation and anabolic responses to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide sythase. Endocrinology 142, 760\u2013766 (2001).","journal-title":"Endocrinology"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1255.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1255","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1255.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:21:52Z","timestamp":1684434112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,22]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["BFnm1255"],"URL":"https:\/\/doi.org\/10.1038\/nm1255","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1027138.327609","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,22]]}}}